B+
Bull case
25%
Probability
Target price
$22.05
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
CBAN
Colony BankcorpCNYSE / Banks
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$19.95
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$18.00
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-01-16
Recent news sentiment (30D)
+25.4
Positive
Company
-
Unavailable
Macro
+25.4
Positive
Pulse
-
Unavailable
Weekly research (10D)
-32.0
Negative
Sentiment proxy
+56.5
Score
AI commentary
Filing tone is constructive: steady dividend policy, active repurchases and modest NIM gains cited in the 10‑Q [#10-Q-2025-09-30]. Market consensus tilts slightly positive (median ≈ $19.95; several outlets report highs near $21–22), supporting a mild upside base case; downside focus remains on acquisition execution and potential credit/reserve surprises.
RankAlpha Sentiment AI - 2026-01-16
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2025-05-15catalystShare repurchase program executionMedium impact
Board authorized repurchase up to 1,000,000 shares (200,000 repurchased by 9/30/2025); continued buybacks can support EPS and provide a valuation floor [#10-Q-2025-09-30].
2025-09-15catalystQuarterly cash dividend payableMedium impact
Board declared $0.15 per share dividend (record/payable dates disclosed in 10-Q); continuity of quarterly payouts supports yield-sensitive demand [#10-Q-2025-09-30].
2026-06-30eventAcquisition expected to close (regulatory approval required)High impact
Announced purchase agreement (filed as a subsequent event) targets closing by Q2 2026; regulatory and execution risk could materially affect valuation if delayed or amended [#10-Q-2025-09-30].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-16 • Updated nightlySource: Internal modelMethodology